Evidence map›Paper›PMID 42018556›Full record

ArticlePloS one2026

In vivo mouse model of calcific myonecrosis induced by injury.

Mai Kuratani, Sho Tsukamoto, Ryo Hamai, Kaori Tsuchiya, Osamu Suzuki, Taketo Yamada, Takenobu Katagiri

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. 15-PGDH inhibition promotes muscle repair and strength recovery during GLP-1 receptor agonist-induced weight loss.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mai KurataniDivision of Biomedical Sciences, Research Center for Genomic Medicine, Saitama Medical University, Saitama, Japan.ORCID https://orcid.org/0000-0002-5605-9197
Sho TsukamotoDivision of Biomedical Sciences, Research Center for Genomic Medicine, Saitama Medical University, Saitama, Japan.
Ryo HamaiDivision of Biomaterials Science and Engineering (Division of Craniofacial Function Engineering), Tohoku University Graduate School of Dentistry, Miyagi, Japan.
Kaori TsuchiyaDivision of Biomaterials Science and Engineering (Division of Craniofacial Function Engineering), Tohoku University Graduate School of Dentistry, Miyagi, Japan.
Osamu SuzukiDivision of Biomaterials Science and Engineering (Division of Craniofacial Function Engineering), Tohoku University Graduate School of Dentistry, Miyagi, Japan.
Taketo YamadaDepartment of Pathology, Saitama Medical University, Saitama, Japan.
Takenobu KatagiriDivision of Biomedical Sciences, Research Center for Genomic Medicine, Saitama Medical University, Saitama, Japan.ORCID https://orcid.org/0000-0001-9304-2098

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skeletal muscle is the major tissue that provides a space and source for bone, which is formed by osteoblasts through the secretion of extracellular matrices, such as type I collagen, and the deposition of hydroxyapatite calcium phosphate crystals. In the present study, we injected notexin, a snake venom, into skeletal muscle to induce local injury. Notexin injection caused local ectopic calcification in muscle fibers within a couple of days, which remained for more than 16 months. In contrast to ectopic bone formation, the damaged muscles after injection of notexin contains neither bone marrow cells, osteoblasts, nor osteoclasts. Histological and chemical analyses of the notexin-induced calcified objects revealed the deposition of stable hydroxyapatite crystals in muscle fibers, which was distinct from ectopic bone formation. We conclude that this in vivo mouse model of calcific myonecrosis induced by injury is useful for studying the molecular mechanisms of and potential therapeutics for calcific myonecrosis.

Indexed as

CalcinosisMuscle, SkeletalMuscular DiseasesAnimalsDisease Models, AnimalDurapatiteElapid VenomsMaleMiceNecrosisDurapatiteElapid Venomsnotexin

Identifiers

PMID42018556
PMCPMC13102222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.